Half-year report · Q2

Period2024-10-01 → 2025-03-31
Filed2025-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥2.7bn2024-10-01 → 2025-03-31Cons.Net sales
Revenue¥5.0bn2023-10-01 → 2024-09-30Cons.Net sales (5-year summary)
Revenue¥2.4bn2023-10-01 → 2024-03-31Cons.Net sales
Operating income¥765m2024-10-01 → 2025-03-31Cons.Operating income
Operating income¥669m2023-10-01 → 2024-03-31Cons.Operating income
Ordinary income¥764m2024-10-01 → 2025-03-31Cons.Ordinary income
Ordinary income¥1.4bn2023-10-01 → 2024-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥675m2023-10-01 → 2024-03-31Cons.Ordinary income
Profit before tax¥764m2024-10-01 → 2025-03-31Cons.Income before income taxes
Profit before tax¥684m2023-10-01 → 2024-03-31Cons.Income before income taxes
Net income (owners)¥518m2024-10-01 → 2025-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥920m2023-10-01 → 2024-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥458m2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income¥518m2024-10-01 → 2025-03-31Cons.Profit loss
Net income¥458m2023-10-01 → 2024-03-31Cons.Profit loss
Total assets¥6.2bnat 2025-03-31Cons.Assets
Total assets¥6.2bnat 2024-09-30Cons.Assets
Total assets¥5.6bnat 2024-03-31Cons.Total assets (5-year summary)
Total liabilities¥2.1bnat 2025-03-31Cons.Liabilities
Total liabilities¥2.3bnat 2024-09-30Cons.Liabilities
Net assets / equity¥4.1bnat 2025-03-31Cons.Net assets
Net assets / equity¥3.8bnat 2024-09-30Cons.Net assets
Net assets / equity¥3.4bnat 2024-03-31Cons.Net assets (5-year summary)
Cash and deposits¥2.9bnat 2025-03-31Cons.Cash and deposits
Cash and deposits¥3.4bnat 2024-09-30Cons.Cash and deposits
Cash & equivalents¥2.9bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥3.4bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.7bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.9bnat 2023-09-30dCons.Cash and cash equivalents
Operating cash flow¥551m2024-10-01 → 2025-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.5bn2023-10-01 → 2024-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥438m2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥539m2024-10-01 → 2025-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥344m2023-10-01 → 2024-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥194m2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥486m2024-10-01 → 2025-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥614m2023-10-01 → 2024-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥434m2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥10.932024-10-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥19.382023-10-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥9.652023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio65.8%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.1%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio60.2%at 2024-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-10-01 → 2025-03-31−¥18m
Reconciling Itemsreconcilingrevenue intersegment2024-10-01 → 2025-03-31−¥18m
Reconciling Itemsreconcilingsegment profit2024-10-01 → 2025-03-31−¥74m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentrevenue2024-10-01 → 2025-03-31¥551m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentrevenue external2024-10-01 → 2025-03-31¥551m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentsegment profit2024-10-01 → 2025-03-31¥57m
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue2024-10-01 → 2025-03-31¥1.8bn
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue external2024-10-01 → 2025-03-31¥1.8bn
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue intersegment2024-10-01 → 2025-03-31¥5m
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentsegment profit2024-10-01 → 2025-03-31¥737m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentrevenue2024-10-01 → 2025-03-31¥344m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentrevenue external2024-10-01 → 2025-03-31¥330m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentrevenue intersegment2024-10-01 → 2025-03-31¥14m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentsegment profit2024-10-01 → 2025-03-31¥44m
Total Of Reportable Segments And Otherssegment totalrevenue2024-10-01 → 2025-03-31¥2.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-10-01 → 2025-03-31¥2.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-10-01 → 2025-03-31¥18m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-10-01 → 2025-03-31¥839m
Reconciling Itemsreconcilingrevenue2023-10-01 → 2024-03-31−¥5m
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2024-03-31−¥5m
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31−¥21m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥613m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥613m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentsegment profit2023-10-01 → 2024-03-31¥15m
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥1.6bn
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥1.6bn
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥1m
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentsegment profit2023-10-01 → 2024-03-31¥641m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥285m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥281m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥4m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentsegment profit2023-10-01 → 2024-03-31¥34m
Total Of Reportable Segments And Otherssegment totalrevenue2023-10-01 → 2024-03-31¥2.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-10-01 → 2024-03-31¥2.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-10-01 → 2024-03-31¥5m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-10-01 → 2024-03-31¥690m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 536
ItemContextValueUnit
Retained earningsPrior1YearInstant3906669000JPY
Retained earningsCurrentQuarterInstant4116682000JPY
Treasury stockPrior1YearInstant-404938000JPY
Treasury stockCurrentQuarterInstant-404938000JPY
Shareholders equityPrior1YearInstant3825850000JPY
Shareholders equityCurrentQuarterInstant4035863000JPY
Foreign currency translation adjustmentPrior1YearInstant8963000JPY
Foreign currency translation adjustmentCurrentQuarterInstant18411000JPY
Valuation and translation adjustmentsPrior1YearInstant8963000JPY
Valuation and translation adjustmentsCurrentQuarterInstant18411000JPY
Net assetsPrior1YearInstant3834813000JPY
Net assetsCurrentQuarterInstant4054275000JPY
Liabilities and net assetsPrior1YearInstant6175564000JPY
Liabilities and net assetsCurrentQuarterInstant6156984000JPY
Net salesPrior1YTDDuration2446366000JPY
Net salesCurrentYTDDuration2661188000JPY
Cost of salesPrior1YTDDuration953603000JPY
Cost of salesCurrentYTDDuration955099000JPY
Gross profitPrior1YTDDuration1492762000JPY
Gross profitCurrentYTDDuration1706089000JPY
Selling general and administrative expensesPrior1YTDDuration823771000JPY
Selling general and administrative expensesCurrentYTDDuration941385000JPY
Operating incomePrior1YTDDuration668991000JPY
Operating incomeCurrentYTDDuration764704000JPY
Interest income noiPrior1YTDDuration259000JPY
Interest income noiCurrentYTDDuration1625000JPY
Gain on sales of goods noiPrior1YTDDuration2502000JPY
Gain on sales of goods noiCurrentYTDDuration1537000JPY
Commission fee noiPrior1YTDDuration4281000JPY
Commission fee noiCurrentYTDDuration4600000JPY
Insurance premiums refunded cancellation noiPrior1YTDDuration6548000JPY
Insurance premiums refunded cancellation noiCurrentYTDDuration-JPY
Miscellaneous income noiPrior1YTDDuration1249000JPY
Miscellaneous income noiCurrentYTDDuration1848000JPY
Non operating incomePrior1YTDDuration14841000JPY
Non operating incomeCurrentYTDDuration9612000JPY
Interest expenses noePrior1YTDDuration3303000JPY
Interest expenses noeCurrentYTDDuration3059000JPY
Foreign exchange losses noePrior1YTDDuration586000JPY
Foreign exchange losses noeCurrentYTDDuration430000JPY
Loss on retirement of noncurrent assets noePrior1YTDDuration716000JPY
Loss on retirement of noncurrent assets noeCurrentYTDDuration6270000JPY
Loss on cancel of lease contracts noePrior1YTDDuration3852000JPY
Loss on cancel of lease contracts noeCurrentYTDDuration-JPY
Miscellaneous loss noePrior1YTDDuration91000JPY
Miscellaneous loss noeCurrentYTDDuration120000JPY
Non operating expensesPrior1YTDDuration8550000JPY
Non operating expensesCurrentYTDDuration9881000JPY
Ordinary incomePrior1YTDDuration675282000JPY
Ordinary incomeCurrentYTDDuration764435000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-09-30pass rounding
balance sheet identityconsolidated 2025-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-10-01/2025-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2024-10-01/2025-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2024-10-01/2025-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass